Polyaspartamide gadolinium complexes containing sulfadiazine groups as potential macromolecular MRI contrast agents

Bioconjugate Chemistry

Volumn 16, Issue 4, 2005, Pages 967-971

  Yan, Guo Ping ^a,b   Liu, Mai Li ^a   Li, Li Yun ^a  

^a WUHAN INSTITUTE OF TECHNOLOGY   (China)

^b Wuhan National Laboratory for Optoelectronics   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINARY ALLOYS; CHELATION; CHLORINE COMPOUNDS; GADOLINIUM COMPOUNDS; IMAGE ENHANCEMENT; LIGANDS; MACROMOLECULES; MAMMALS; TUMORS;

AMINOBUTYL; DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; GADOLINIUM COMPLEXES; LIGAND COMPLEXES; MR IMAGING; MR-IMAGES; MRI CONTRAST AGENTS; POLYASPARTAMIDES; RELAXIVITY; SIDE-CHAINS;

MAGNETIC RESONANCE IMAGING;

AMIDE; ASPARTIC ACID DERIVATIVE; CONTRAST MEDIUM; GADOLINIUM; LIGAND; PENTETIC ACID DERIVATIVE; POLY ALPHA,BETA [N (2 AMINOETHYL)ASPARTAMIDE]GADOLINIUM DIETHYLENETRIAMINEPENTAACETIC ACID SULFADIAZINE; POLY ALPHA,BETA [N (2 HYDROXYETHYL)ASPARTAMIDE]GADOLINIUM DIETHYLENETRIAMINEPENTAACETIC ACID SULFADIAZINE; POLY ALPHA,BETA [N (3 HYDROXYPROPYL)ASPARTAMIDE]GADOLINIUM DIETHYLENETRIAMINEPENTAACETIC ACID SULFADIAZINE; POLY ALPHA,BETA [N (4 AMINOBUTYL)ASPARTAMIDE]GADOLINIUM DIETHYLENETRIAMINEPENTAACETIC ACID SULFADIAZINE; POLY ALPHA,BETA [N (6 AMINOHEXYL)ASPARTAMIDE]GADOLINIUM DIETHYLENETRIAMINEPENTAACETIC ACID SULFADIAZINE; SULFADIAZINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHELATION; COMPLEX FORMATION; INFRARED SPECTROSCOPY; LIVER CELL CARCINOMA; MACROMOLECULE; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; ULTRAVIOLET SPECTROSCOPY;

EID: 22644445311     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc050026l     Document Type: Article

References (19)

1. Lauterbur, P. C. (1973) Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature 242, 190-191.
2. Lauffer, R. B. (1987) Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev. 87, 901-927.
3. Caravan, P., Ellison, J. J., Mcmurry, T. J., and Lauffer, R. B. (1999) Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 99, 2293-2352.
4. Wen, J., Zhuo, R. X., and Wang, L. (1998) Aromatic DTPA-Bis(amide) gadolinium complexes as hepatobiliary contrast agents for magnetic resonance imaging. Chin. J. Magn. Reson. 15 (3), 217-221.
5. Van Beer, B. E., Gallez, B., and Pringot, J. (1997) Contrast-enhanced MR imaging of the liver. Radiology 203, 297-306.
6. Yan, G. P., and Zhuo, R. X. (2001) Research progress of magnetic resonance imaging contrast agents. Chin. Sci. Bull. 46 (7), 531-538.
7. Giammona, G., Carlisi, B., and Palazzo, S. (1987) Reaction of α,β-poly (N-hydroxyethyl)-D,L-aspartamide with derivatives of carboxylic acids. J. Polym. Sci. Polym. Chem. 25, 2813-2818.
8. Giammona, G., Carlisi, B., Cavallaro, G., Donato, I., Pinio, F., and Turco Liveri V. (1990) Calorimetric investigation of the interaction between α,β-Poly (N-hydroxy-ethyl)-D,L-aspartamide and surfactants. Int. J. Pharm. 64, 239-242.
9. Giammona, G., Carlisi, B., Pitarresi, G., and Fontana, G. (1991) Hydrophilic and hydropholic polymeric derivatives of antiinflammatory agents such as Alclofenac, Ketoprofen and Ibuprofen. J. Bioact. Compat. Polym. 6, 129-141.
10. Giammona, G., Carlisi, B., Pitarresi, G., Cavallaro, G., and Turco Liveri, V. (1992) Water-soluble copolymers of an antiviral agent: synthesis and their interaction with a biomembrane model. J. Controlled Release 22, 197-204.
11. Giammona, G., Fontana, G., Pitarresi, G., and Carlisi, B. (1998) Coupling of the antiviral agent zidovudine to polyaspartamide and in vitro drug release studies. J. Controlled Release 54, 321-331.
12. Yan, G. P., Zhuo, R. X., Xu, M. Y., Li, L. Y., and Tang, Y. F. (2001) Liver-targeting macromolecular MRI contrast agents. Sci. China, Ser. B 44 (4), 344-352.
13. Bartulin, J., Przybylski, M., Ringsdorf, H., and Ritter, H. (1994) Pharmacologically active polymers, 6: sulfadiazine and boron derivatives as potential carriers for polymers into cancer tissue. Macromol. Chem. 175, 1007-1010.
14. Huang, J. L., Wang, H. Y., and Zhou, C. L. (1995) Ring-opening polymerization of ethylene oxide by anion initiation using sulfadiazine as parents compound. J. Appl. Polym. Sci. 58, 11-8.
15. Yan, G. P., Zheng, C. Y., Cao, W., Li, W., Li, L. Y., Liu, M. L., Zhang, Y. X., and Zhou, R. X. (2003) Synthesis and preliminary evaluation of gadolinium complexes containing sulfonamide groups as potential MRI contrast agents. Radiography 9, 35-41.
16. Shi, F. Q. (1990) How to copy the disease model of animals. YiXue DongWu ShiYan FangFa, pp 226-232, Chapter 4, RenMing WeiSheng Press, Bejing, China.
17. Yan, G. P., Zhuo, R. X., and Zheng C. Y. (2001) Study on the anticancer drug 5-fluorouracil-conjugated polyaspartamides containing hepatocyte-targeting group. J. Bioact. Compat Polym. 16 (4), 277-293.
18. Yan, G. P., Zhuo, R. X., Zhang, X., Zhang, X., Li, L. Y., and Liu, M. L. (2002) Tumor-selective macromolecular MRI contrast agents. J. Bioact. Compat. Polym. 17 (2), 139-151.
19. Neuse, E. M., Perlwitz, A. G., and Schmitt, S. (1991) Water-soluble polyamides as potential drug carriers. Angew. Makromol. Chem. 192, 35-50.